Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis

The paper presents the results of recent studies of the efficacy of golimumab (GLM) in the treatment of uveitis in patients with ankylosing spondylitis (AS). The data obtained in these studies suggest that GLM is highly effective in relieving and preventing uveitis attacks. However, all the given st...

Full description

Saved in:
Bibliographic Details
Main Authors: T. V. Dubinina, Sh. F. Erdes
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2016-09-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/705
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849303390495965184
author T. V. Dubinina
Sh. F. Erdes
author_facet T. V. Dubinina
Sh. F. Erdes
author_sort T. V. Dubinina
collection DOAJ
description The paper presents the results of recent studies of the efficacy of golimumab (GLM) in the treatment of uveitis in patients with ankylosing spondylitis (AS). The data obtained in these studies suggest that GLM is highly effective in relieving and preventing uveitis attacks. However, all the given studies have a number of disadvantages; primarily they have included a limited number of patients. Further prospective randomized clinical trials with large sample sizes are required to evaluate the efficacy and safety of GLM for the treatment of uveitis in patients with spondyloarthritis.
format Article
id doaj-art-c4d0892e16554ffab8d11bf45a3c8794
institution Kabale University
issn 1996-7012
2310-158X
language Russian
publishDate 2016-09-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-c4d0892e16554ffab8d11bf45a3c87942025-08-20T03:59:57ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2016-09-01103778010.14412/1996-7012-2016-3-77-801992Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitisT. V. Dubinina0Sh. F. Erdes1V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115552V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia 34A, Kashirskoe Shosse, Moscow 115552The paper presents the results of recent studies of the efficacy of golimumab (GLM) in the treatment of uveitis in patients with ankylosing spondylitis (AS). The data obtained in these studies suggest that GLM is highly effective in relieving and preventing uveitis attacks. However, all the given studies have a number of disadvantages; primarily they have included a limited number of patients. Further prospective randomized clinical trials with large sample sizes are required to evaluate the efficacy and safety of GLM for the treatment of uveitis in patients with spondyloarthritis.https://mrj.ima-press.net/mrj/article/view/705uveitisankylosing spondylitisspondyloarthritistumor necrosis factor-α inhibitorsgolimumab
spellingShingle T. V. Dubinina
Sh. F. Erdes
Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
Современная ревматология
uveitis
ankylosing spondylitis
spondyloarthritis
tumor necrosis factor-α inhibitors
golimumab
title Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
title_full Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
title_fullStr Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
title_full_unstemmed Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
title_short Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
title_sort efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
topic uveitis
ankylosing spondylitis
spondyloarthritis
tumor necrosis factor-α inhibitors
golimumab
url https://mrj.ima-press.net/mrj/article/view/705
work_keys_str_mv AT tvdubinina efficacyofgolimumabintreatinguveitisinpatientswithankylosingspondylitis
AT shferdes efficacyofgolimumabintreatinguveitisinpatientswithankylosingspondylitis